Search | TVST | ARVO Journals

Showing 1 – 20 of 40

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Primary open angle glaucoma polygenic risk score can identify individuals at low risk of disease onset in the Ocular Hypertension Treatment Study

Nazlee Zebardast; Sayuri Sekimitsu; Kanza Aziz; Yan Zhao; Rishabh Singh; John H Fingert; Mae O Gordon; Michael A Kass; Todd E Scheetz; Ayellet Segre; James D Brandt; Janey L Wiggs

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):996.

ARVO Annual Meeting Abstract June 2024

Ocular Hypertension Treatment Study: 20 yr quality of life (QoL) outcomes

Mae O Gordon; Feng Gao; Michael A Kass; Julia Huecker; Pradeep Y Ramulu; Stuart Keith Gardiner; Linda M Zangwill

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4622.

ARVO Annual Meeting Abstract June 2023

Baseline visual field patterns identified by archetypal analysis are associated with glaucoma onset and progression in the Ocular Hypertension Treatment Study

Rishabh Singh; Yan Zhao; John H Fingert; Mae O Gordon; Michael A Kass; Yuyang Luo; Ayellet V. Segre; Janey L Wiggs; Tobias Elze; Nazlee Zebardast

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):349.

ARVO Annual Meeting Abstract June 2023

Prediction model of visual field progression in the Ocular Hypertension Treatment Study

Mae O Gordon; Dale K Heuer; Eve J Higginbotham; Richard K Parrish; Chris A Johnson; Lei Liu; Michael A Kass

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):104.

ARVO Annual Meeting Abstract June 2023

Duration of viral load, clinical signs, and symptoms in qPCR-confirmed adenoviral conjunctivitis

Christina E Morettin; Jennifer S Harthan; Tammy Than; Ellen Shorter; Andrew TE Hartwick; Julie B Huecker; Spencer D Johnson; Mary K Migneco; Meredith Whiteside; Christian K Olson; Christopher S Alferez; Tave van Zyl; Mae O Gordon

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2938.

ARVO Annual Meeting Abstract June 2023

Recruitment in the 80VIP study

Katie McAnnis; Jack Rees; Stuart Keith Gardiner; Lisa John; Mae O Gordon; Rohit Varma; Elizabeth Eckstrom; Greg Flamme; Kristy Dieters

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4243.

ARVO Annual Meeting Abstract June 2023

Vision Tests Associated with At-Risk Driving in Older Adults With and Without Glaucoma

Anika Mittal; Sharon Sabapathypillai; Monica Perlmutter; Peggy Barco; Bradley Wilson; David Carr; Mae O Gordon; Anjali Bhorade

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4228.

Articles August 2021

Predictive Accuracy and Densitometric Analysis of Point-of-Care Immunoassay for Adenoviral Conjunctivitis

PDF

Spencer D. Johnson; Jennifer S. Harthan; Tammy Than; Mary K. Migneco; Ellen Shorter; Meredith M. Whiteside; Christina E. Morettin; Christian K. Olson; Crystal A. Rosemann; Mathew S. Margolis; Leonard W. Haertter; Julia B. Huecker; Bojana Rodic-Polic; Richard S. Buller; Gregory A. Storch; Mae O. Gordon; Andrew T. E. Hartwick
TAGS: adenoviral conjunctivitis, adenoviruses, densitometry, immunoassay, eye, laboratory test finding
Trans. Vis. Sci. Tech.. 2021; 10(9):30. https://doi.org/10.1167/tvst.10.9.30

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2021

Reducing Adenoviral Patient Infected Days (RAPID) Study: Correlation of adenoviral load with severity of adenoviral conjunctivitis and viral clearance over 21 days

Christina E Morettin; Jennifer S Harthan; Julia Huecker; AA Chamila D Perera; Tammy P Than; Ellen Shorter; Meredith Whiteside; Spencer Johnson; Andrew Hartwick; Mathew Margolis; Mary K Migneco; Christopher Alferez; Devon Camp; Len Haertter; Mae O Gordon

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):696.

ARVO Annual Meeting Abstract July 2019

The Reducing Adenoviral Patient-Infected Days (RAPID) Study: Safety and Tolerability of One-Time, In-Office Application of 5% Povidone-Iodine in the Treatment of Adenoviral Conjunctivitis

Ellen Shorter; Tammy Than; Meredith Whiteside; Jennifer S Harthan; Mathew Margolis; Spencer Johnson; Mary Migneco; Christina Morettin; Christian K. Olson; Andrew Hartwick; Julia Huecker; Mae O Gordon

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4703.

ARVO Annual Meeting Abstract July 2019

Reducing Adenoviral Patient-Infected Days (RAPID) Study: A Randomized Trial Assessing Efficacy of One Time, In-Office Application of 5% Povidone-Iodine in Treatment of Adenoviral Conjunctivitis

Andrew Hartwick; Tammy Than; Bojana Rodic-Polic; Spencer Johnson; Mary Migneco; Ellen Shorter; Jennifer S Harthan; Christina Morettin; Meredith Whiteside; Christian K. Olson; Mathew Margolis; Julia Huecker; Gregory Storch; Mae O Gordon

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6257.

ARVO Annual Meeting Abstract July 2019

Crowdsourcing to assess resident surgical skill proficiency in cataract surgery

Grace L Paley; Jenny Chen; Bradley Wilson; Mae O Gordon; Susan M Culican

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):475.

ARVO Annual Meeting Abstract July 2019

Using a Machine Learning Technique Called Kalman Filtering to Forecast Conversion from Ocular Hypertension to Primary Open Angle Glaucoma

Gian-Gabriel P Garcia; Mariel Lavieri; Chris Andrews; Xiang Liu; Mark P Van Oyen; Michael Kass; Mae O Gordon; Joshua D Stein

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2857.

ARVO Annual Meeting Abstract July 2018

Reducing Adenoviral Patient Infected Days (RAPID): Prevalence of Polymerase Chain Reaction (PCR) Confirmed Adenovirus Among Patients Presenting With Acute Conjunctivitis

Mary Migneco; Mathew Margolis; Christina Morettin; Tammy Than; Meredith Whiteside; Ellen Shorter; Jennifer S Harthan; Spencer Johnson; Andy Hartwick; Kelly Olsen; Tave van Zyl; Julia Huecker; Crystal Rosemann; Mae O. Gordon

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):115.

ARVO Annual Meeting Abstract July 2018

The Ocular Hypertension Treatment Study: Aging and Reliability of Visual Fields

Mae O. Gordon; Julia Huecker; Kimberly Plumb; Laura Lemming; Michael A Kass; John L Keltner; Michael Wall; Chris A Johnson

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3025.

ARVO Annual Meeting Abstract June 2017

A Novel Quantitative Approach for Analyzing Glaucomatous Disc Hemorrhages: Identifying the Source of the Blood

Jonathan Chou; Clara C Cousins; John B Miller; Lucy Q Shen; Brian J Song; Mae O Gordon; Michael A Kass; Louis R Pasquale

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3982.

ARVO Annual Meeting Abstract June 2017

Reducing Adenoviral Patient Infected Days (RAPID) Study: Association of Clinical Signs and Symptoms with qPCR confirmed Adenoviral Conjunctivitis

Ellen Shorter; Mary Migneco; Jennifer S Harthan; Meredith Whiteside; Christina Morettin; Tammy Than; Spencer Johnson; Julia Huecker; Andrew T E Hartwick; Mae O Gordon

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4360.

ARVO Annual Meeting Abstract September 2016

The Ocular Hypertension Treatment Study (OHTS): Self-Reported Functional Limitations in Early Glaucoma

Mae O Gordon; Julie Huecker; Ling Chen; Feng Gao; Michael Kass

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5594.

ARVO Annual Meeting Abstract September 2016

Reducing Adenoviral Patient Infected Days (RAPID) Planning Study: Agreement between Clinician and AdenoPlus TM in the Diagnosis of Adenoviral Conjunctivitis

Mary Migneco; Mae O Gordon; Andrew T E Hartwick; Spencer Johnson; Jennifer Harthan; Christina Morettin; Tammy Than; Ellen Shorter; Julie Huecker

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3503.

Genetics August 2016

A Common Variant in MIR182 Is Associated With Primary Open-Angle Glaucoma in the NEIGHBORHOOD Consortium

PDF

Yutao Liu; Jessica Cooke Bailey; Inas Helwa; W. Michael Dismuke; Jingwen Cai; Michelle Drewry; Murray H. Brilliant; Donald L. Budenz; William G. Christen; Daniel I. Chasman; John H. Fingert; Douglas Gaasterland; Terry Gaasterland; Mae O. Gordon; Robert P. Igo, Jr; Jae H. Kang; Michael A. Kass; Peter Kraft; Richard K. Lee; Paul Lichter; Sayoko E. Moroi; Anthony Realini; Julia E. Richards; Robert Ritch; Joel S. Schuman; William K. Scott; Kuldev Singh; Arthur J. Sit; Yeunjoo E. Song; Douglas Vollrath; Robert Weinreb; Felipe Medeiros; Gadi Wollstein; Donald J. Zack; Kang Zhang; Margaret A. Pericak-Vance; Pedro Gonzalez; W. Daniel Stamer; John Kuchtey; Rachel W. Kuchtey; R. Rand Allingham; Michael A. Hauser; Louis R. Pasquale; Jonathan L. Haines; Janey L. Wiggs
TAGS: micrornas, neighborhood, open-angle glaucoma, glaucoma, body tissue, hypertension, exosomes
Invest. Ophthalmol. Vis. Sci.. 2016; 57(10):4528-4535. https://doi.org/10.1167/iovs.16-19688

Includes: Supplemental Content

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Primary open angle glaucoma polygenic risk score can identify individuals at low risk of disease onset in the Ocular Hypertension Treatment Study

Ocular Hypertension Treatment Study: 20 yr quality of life (QoL) outcomes

Baseline visual field patterns identified by archetypal analysis are associated with glaucoma onset and progression in the Ocular Hypertension Treatment Study

Prediction model of visual field progression in the Ocular Hypertension Treatment Study

Duration of viral load, clinical signs, and symptoms in qPCR-confirmed adenoviral conjunctivitis

Recruitment in the 80VIP study

Vision Tests Associated with At-Risk Driving in Older Adults With and Without Glaucoma

Predictive Accuracy and Densitometric Analysis of Point-of-Care Immunoassay for Adenoviral Conjunctivitis

Reducing Adenoviral Patient Infected Days (RAPID) Study: Correlation of adenoviral load with severity of adenoviral conjunctivitis and viral clearance over 21 days

The Reducing Adenoviral Patient-Infected Days (RAPID) Study: Safety and Tolerability of One-Time, In-Office Application of 5% Povidone-Iodine in the Treatment of Adenoviral Conjunctivitis

Reducing Adenoviral Patient-Infected Days (RAPID) Study: A Randomized Trial Assessing Efficacy of One Time, In-Office Application of 5% Povidone-Iodine in Treatment of Adenoviral Conjunctivitis

Crowdsourcing to assess resident surgical skill proficiency in cataract surgery

Using a Machine Learning Technique Called Kalman Filtering to Forecast Conversion from Ocular Hypertension to Primary Open Angle Glaucoma

Reducing Adenoviral Patient Infected Days (RAPID): Prevalence of Polymerase Chain Reaction (PCR) Confirmed Adenovirus Among Patients Presenting With Acute Conjunctivitis

The Ocular Hypertension Treatment Study: Aging and Reliability of Visual Fields

A Novel Quantitative Approach for Analyzing Glaucomatous Disc Hemorrhages: Identifying the Source of the Blood

Reducing Adenoviral Patient Infected Days (RAPID) Study: Association of Clinical Signs and Symptoms with qPCR confirmed Adenoviral Conjunctivitis

The Ocular Hypertension Treatment Study (OHTS): Self-Reported Functional Limitations in Early Glaucoma

Reducing Adenoviral Patient Infected Days (RAPID) Planning Study: Agreement between Clinician and AdenoPlus TM in the Diagnosis of Adenoviral Conjunctivitis

A Common Variant in MIR182 Is Associated With Primary Open-Angle Glaucoma in the NEIGHBORHOOD Consortium

To View More...

You must be signed into an individual account to use this feature.